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Nonischemic 5/6 nephrectomized rat (NefR) is a model of chronic kidney disease. However, little is known about vascular
dysfunction and its relation with hypertension in NefR. Aims. To evaluate possible alterations of endothelial function, NO-
bioavailability, and basal tone in aorta from NefR and the role of oxidative stress. Sprague Dawley rats were divided into sham
rats (SR), NefR, and NefR treated with tempol (NefR-T). Mean arterial pressure (MAP) and renal function were determined. In
isolated aortic rings the following was measured: 1-endothelial function, 2-basal tone, 3-NO levels, 4-membrane potential (MP),
and 5-oxidative stress. NefR increased MAP (SR: 119 ± 4mmHg; 𝑛 = 7; NefR: 169 ± 6; 𝑛 = 8; 𝑃 < 0.001). Tempol did not modify
MAP (NefR-T: 168 ± 10; 𝑛 = 6; 𝑃 < 0.001). NefR showed endothelial dysfunction, increased basal tone and decreased NO levels
(SR: 32 ± 2 nA; 𝑛 = 7, NefR: 10 ± 2; 𝑛 = 8; 𝑃 < 0.001). In both in vitro and in vivo tempol improves basal tone, NO levels, and
MP. Oxidative stress in NefR was reverted in NefR-T. We described, for the first time, that aorta from NefR presented increased
basal tone related to endothelial dysfunction and decreased NO-bioavailability. The fact that tempol improves NO-contents and
basal tone, without decrease MAP, indicates that oxidative stress could be implicated early and independently to hypertension, in
the vascular alterations.
1. Introduction
It is known that, in the chronic kidney disease (CKD), the
endothelial dysfunction could be cause and/or consequence
of the kidney damage. Nonischemic 5/6 nephrectomized rat
(NefR) is a model used to evaluate the evolution of renal
abnormalities in CKD [1]. A lot of evidence has reported that
the decrease of renal mass is a cardiovascular risk factor [2].
Recently the concept that reduced renal mass is associated
with low birth weight as a cardiovascular risk factor has
gained importance. These suggestions have been supported
by both clinical [3] and experimental evidence [4]. Xie
et al. showed that rats with low birth weight impaired renal
function and developed hypertension.
In NefR, the impact of the loss of renal mass, its relation-
ship to vascular dysfunction, and the development of hyper-
tension have been little studied. It has been shown, in rats,
that the renal mass reduction (2/3) associated with ischemia
of contralateral kidney was able to induce hypertension [5].
In this situation, the hypertension has been explained by
renin-angiotensin system activation.However, the implicated
mechanisms in the development of hypertension in NefR
without renal ischemia are unclear. In this model, to the best
of our knowledge, arterial basal tone, endothelial function,
and nitric oxide (NO), which are known to be involved in
the regulation of arterial pressure have not been evaluated
in a comprehensive way. In NefR, some authors did not find
hypertension [6, 7]; however other authors found elevated
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values of blood pressure [8]. Recently, Toba et al. [9] showed
that NefR developed hypertension, which does not decrease
with the administration of the substrate of NO synthase
(NOS), L-arginine.
On the other hand, it is known that models of hyper-
tension, like spontaneously hypertensive rats (SHR) [10],
have alterations in basal tone of vascular smooth muscle
cells (VSMC). Accordingly, we previously demonstrated that
arterial vessels from SHR [11] and coarctation-hypertensive
rats [12] showed increased basal tone. This increased basal
tone was evidenced by a relaxant response to sodium nitro-
prusside (SNP) and atrial natriuretic peptide. Other findings
from our laboratory, in isolated human arteries, showed an
increased basal tone in both hypertensive and normotensive
patients [13], indicating that the basal tone of VSMC is not
only a consequence of the development of hypertension.
Consequently, the integrity of the vascular function and the
bioavailability of NO could play a pivotal role in vascular
homeostasis and its alteration is involved in an increased
basal tone. Another factor that could alter the basal tone is
the oxidative stress [14] through inactivation of NO and alter-
ation of vascular reactivity.Moreover, the oxidative stressmay
also produce a direct vasoconstrictor effect [15] accompanied
to an increase of myogenic tone. NADPH oxidase is a source
of superoxide anion in the vessel wall. Superoxide anion is
involved in increased blood pressure, vascular hypertrophy,
and endothelial dysfunction [15, 16] and plays a role in the
development of spontaneous vascular tone [11].
In the light of these considerations, the objectives of the
present work were to evaluate possible alterations of the
endothelial function, NO bioavailability, and basal tone in
aortic rings from NefR and establish the role of oxidative
stress.
2. Methods
2.1. Animal Model. In order to obtain a nonischemic model
of renal mass reduction, two surgeries were performed to
male Sprague Dawley rats: first, the resection of 2/3 of the
left kidney (the two poles) and second, after 2 weeks, a
complete resection of the right kidney. After each surgery
the animals were placed in acclimatized cages until recov-
ery. After 13-14 weeks of second surgery, creatinine clear-
ance (Ccr) (Wiener Lab, Argentina) and microalbuminuria
(BioSystem kit, Spain) were measured in metabolic cage by
24 hours. Mean arterial pressure (MAP) was measured by
direct method through cannulation of right carotid with
a catheter connected to a pressure transductor [12]. In
all surgical procedures the animals were anesthetized with
sodium pentobarbital (45mg/kg intraperitoneal). In all cases
the rats were sacrificed under anesthesia by exsanguination.
The thoracic aorta was dissected, immersed in Krebs solution
(in mmol/L: NaCl 122, KCl 5.9, NaHCO
3
25, CaCl
2
1.9,
MgSO
4
1.2, and glucose 11), and cut into 5mm rings (1 to 4
for rat). In some experiments the endothelium was removed
(rubbed rings). The rats were divided into 2 groups: one
without treatment (NefR, 𝑛 = 8) and other treated with
tempol (1mmol/L in drinking water) since the first surgery
until sacrifice (NefR-T, 𝑛 = 6). Results were compared with
sham rats (SR: 𝑛 = 7). In SR the two surgeries were performed
without removal of any portion of the renal mass.
All experiments were carried out according to the guide-
lines of the institutional ethics committee.
2.2. Contractility. The rings were fixed in an isolated organ
chamber with 6mL of Krebs solution maintained at 37∘C,
gassed with a mixture of 95% O
2
and 5% CO
2
(pH 7.4)
[13], and connected to a force transducer (GOULD UC2,
USA) and to a recorder (K&Z BD41, Holland). The rings
were equilibrated at 2 g of tension by 120min, which was
found to be the optimal tension for KCl-induced contraction
(100mM). KCl-contraction was similar in all groups (SR:
1392 ± 150mg; 𝑛 = 7; NefR: 1187 ± 131; 𝑛 = 8 and NefR-T:
1028 ± 154; 𝑛 = 6; 𝑃: NS). Data were expressed in milligrams
(mg) of tension.
To evaluate the spontaneous basal tone, the endothelium-
independent agent (SNP) was added to rings not previously
exposed to any vasoactive agent [12]. For this purpose, SNP
was used to maximal dose (10−5M), which was found to be
the optimal concentration for SNP-induced relaxation (100%)
of the precontracted rings with norepinephrine (NE).
In some rings, SNP-response was evaluated after incu-
bation (20min) with N𝜔-nitro-L-arginine methyl ester (L-
NAME) 10−4M.
In NefR, in order to evaluate the possible role of oxidative
stress in the basal tone, unrubbed aortic rings were sub-
jected to a “preconditioning manoeuvre.” For this purpose
some aortic rings were incubated with tempol 10−5M or
diphenyliodonium (DPI) 10−4M during 120min (precon-
ditioned vessels). After that, this agent was removed by
washing (40min) with Krebs solution and SNP stimulation
was performed.
Endothelial function was tested with cumulative dose
response curve to acetylcholine (Ach) (10−9–10−5M) in NE
10−5M-contracted rings. In all cases the maximal relaxation
was induced by Ach 10−5M. Control experiments were
performed in rings incubated (20min)with L-NAME 10−4M.
2.3. Nitrites. Nitrites were measured, by the Griess reaction,
in samples from the bath of isolated aortic rings subjected to
stretching (2 g) [13]. In some rings, nitrites were measured
in the presence (incubation by 20min) of L-NAME 10−4M,
tempol 10−5M, or DPI 10−4M. Data were expressed in
pmol/mg of tissue.
2.4. Direct NO Measurement. NO release was measured in
real time with an ISO-NOP electrode (WPI, USA) connected
to a recorder (Apollo 4000, WPI, USA) in isolated aortic
rings subjected to stretching [17] at optimal tension for KCl-
induced contraction (2 g). Some rings were treated with L-
NAME 10−4M or tempol 10−5M. Data were expressed in
nanoamperes (nA).
2.5. Electrophysiological Studies. Membrane potential (MP)
was recorded in VSMC with electrodes connected to an
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Table 1: Clinical characteristics of rats.
Rat
SR (𝑛 = 7) NefR (𝑛 = 8) NefR-T (𝑛 = 6)
Body weight (g) 226.3 ± 8.4 218.5 ± 4.5 220.5 ± 5.2
Food intake (g/24 hs) 24.7 ± 3.8 18.2 ± 1.8 23.0 ± 3.6
Water intake (mL/24 hs) 22.7 ± 1.6 41.6 ± 4.1∗∗∗ 40.8 ± 2.6†††
Urinary volume (mL/24 hs) 10.7 ± 2.2 28.1 ± 3.7∗∗∗ 23.5 ± 2.4++
Glucose (mg/dL) 80.0 ± 0.1 83.2 ± 1.3 82.1 ± 1.1
Mean arterial pressure (mmHg) 119 ± 4 169 ± 6∗∗∗ 168 ± 10†††
Heart rate (beats/min) 365 ± 21 353 ± 16 354 ± 15
Creatinine clearance (mL/min) 0.59 ± 0.1 0.11 ± 0.01∗∗∗ 0.22 ± 0.04††,+
Microalbuminuria (mg/24 hs) 6.8 ± 1.2 62.9 ± 9.8∗∗∗ 22.1 ± 5.2†,+++
SR: sham rats; NefR: nefrectomized rats; NefR-T: NefR treated with tempol; ∗∗∗𝑃 < 0.001 NefR versus SR; †𝑃 < 0.05, ††𝑃 < 0.01, and †††𝑃 < 0.001 NefR-T
versus SR; +𝑃 < 0.05, ++𝑃 < 0.01, and +++𝑃 < 0.001 NefR-T versus NefR. One way ANOVA.
amplifier (WPI, USA) and to a recorder (Gould, USA) [18]
in basal conditions and after in vitro treatment with tempol
10−5M. Results were expressed in mV as differences between
MP obtained by KCl 100mM (SR: +7.0±2.7mV; 𝑛 = 6; NefR:
+6.0±1.7; 𝑛 = 6; NefR-T: +6.6±1.2;𝑃: NS) andMP registered
(basal or tempol).
2.6. Oxidative Stress. Total, reduced (GSH), and oxidized
glutathione (GSSG) and thiobarbituric acid reactive sub-
stances (TBARS) were determined in aorta homogenates by
spectrophotometry [17, 19, 20] and correlated with protein
contents.
2.7. Statistical Analyses. Results were expressed in mean
± standard error. Statistical analyses were performed with
Statistica 5.0 programs. Student’s 𝑡-test for paired samples
and ANOVA (One or Two way with Newman-Keuls posttest)
were used when appropriate. Results were considered signif-
icant when 𝑃 < 0.05.
3. Results
Clinical characteristics of the animals are shown in Table 1.
Resection of 5/6 of renal mass (NefR) induces an increase
of MAP and microalbuminuria, whereas Ccr was decreased.
In vivo treatment with tempol (NefR-T) was ineffective in
reversing the hypertension but was able to improve Ccr and
microalbuminuria (Table 1). Urinary nitrites were higher in
SR (417.6 ± 59.2 pmol/mL; 𝑛 = 6) than NefR (94.5 ± 18.5;
𝑛 = 6; 𝑃 < 0.001; One way ANOVA) and NefR-T (227.5 ±
49.0 pmol/mL; 𝑛 = 6; 𝑃 < 0.01; One way ANOVA). NefR-T
improves urinary nitrites in respect to NefR (𝑃 < 0.05; One
way ANOVA).
3.1. Endothelial Function. Endothelial function, checked
through Ach-vasorelaxant response, was present in SR aortic
rings: −796 ± 187mg (−70 ± 18% of NE-contraction, 𝑛 = 7).
A significant decrease of Ach-response was observed inNefR:
−70 ± 10mg (−30 ± 4% of NE-contraction, 𝑛 = 8; 𝑃 < 0.01
in respect to SR; One way ANOVA). NefR-T improves
endothelial function: the Ach-vasorelaxation was −312 ± 169
(−50 ± 6% of NE-contraction, 𝑛 = 6; 𝑃 < 0.05 in respect
to NefR; One way ANOVA). There were not significant
differences in Ach-response between SR and NefR-T (𝑃:
NS; One way ANOVA). In all cases, rubbed manoeuvres or
incubation with L-NAME abolished the Ach-response (data
not shown).
3.2. Basal Tone. Figure 1(a) shows recorders from typical
experiments of the effect of SNP on the basal tone. SNP had
no effect on aortic rings from SR (upper panel). However,
SNP produced a vasorelaxant response in aortic rings from
NefR (middle panel), indicating an increased basal tone. In
vivo treatment with tempol (NefR-T) reverted near com-
pletely the SNP effect (down panel), indicating a decreased
basal tone. The averages of these responses are shown in
Figure 1(b) (first group of bars). In any case the rubbed
manoeuvres did not modify the effect of SNP (Figure 1(b),
second group of bars).
In vitro incubation with L-NAME did not modify SNP-
response on basal tone in aortic rings from SR (Krebs: −41 ±
15mg, 𝑛 = 6 versus L-NAME: −38 ± 15, 𝑛 = 6; 𝑃: NS), NefR
(Krebs: −1052 ± 149mg, 𝑛 = 8 versus L-NAME: −967 ± 78,
𝑛 = 6; 𝑃: NS), and NefR-T (Krebs: −168±44mg, 𝑛 = 6 versus
L-NAME: −206 ± 22, 𝑛 = 6; 𝑃: NS).
On the other hand, in aortic rings from NefR, in vitro
preconditioning manoeuvre with antioxidant agents was
effective to reverse the increased basal tone. Preconditioning
with tempol (10−5Mby 120min) decreased the SNP response.
The effect was −244 ± 83mg (−77 ± 8% from baseline, 𝑛 = 6;
𝑃 < 0.01). Similar effect was obtained by preconditioning
with DPI (10−4Mby 120min): −87±3% from baseline; 𝑛 = 6;
𝑃 < 0.01.
3.3. Nitrite Levels. Figure 2 shows nitrite levels in aortic rings.
Nitrite levels were higher in SR than NefR. NefR-T improves
the nitrite levels. In all cases rubbing manoeuvres decreased
nitrites (Figure 2).
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Figure 1: Effect of SNP 10−5Mon basal tone. (a) Tracing of a typical experiment of administration of SNP (arrows) on basal tone in unrubbed
aortic ring from SR (upper), NefR, (middle) and NefR-T (lower). (b) Average of effect of SNP on basal tone in unrubbed (white bars) and
rubbed (black bars) aortic rings from SR, NefR, and NefR-T. ∗∗∗𝑃 < 0.001 NefR versus SR; ∗𝑃 < 0.05 NefR-T versus SR. Two way ANOVA.
Data are expressed as mean ± standard error. The number of rings is given in parentheses.
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Figure 2: Nitrite contents in aortic rings of SR (white bars), NefR
(black bars), and NefR-T (gray bars) with (first group of bars:
unrubbed) or without functional endothelium (second group of
bars: rubbed) at 15min in the experiment. ∗∗∗𝑃 < 0.001 NefR
and NefR-T versus SR; +++𝑃 < 0.001 NefR-T versus NefR; †††𝑃 <
0.001 rubbed versus unrubbed rings. Two way ANOVA. Data are
expressed as mean ± standard error. The number of rings is given in
parentheses.
In the presence of L-NAME 10−4M, nitrite levels were
decreased in unrubbed rings from SR (−90 ± 2% from
baseline; 𝑛 = 6; 𝑃 < 0.001; paired Student’s 𝑡-test), NefR
(−75 ± 10% from baseline; 𝑛 = 6; 𝑃 < 0.001; paired Student’s
𝑡-test), andNefR-T (−92±5% from baseline; 𝑛 = 6;𝑃 < 0.001;
paired Student’s 𝑡-test).
In NefR aortic rings, in vitro administration of tempol
increased nitrite levels. The nitrite values in the presence of
tempol 10−5M were 6369 ± 433 pmol/mg (𝑛 = 6; 89 ± 13%
increase over baseline; 𝑃 < 0.01; paired Student’s 𝑡-test).
Similar results were observed with in vitro administration of
DPI 10−4M (73 ± 14% over baseline, 𝑛 = 7; 𝑃 < 0.01; paired
Student’s 𝑡-test). However, in SR and NefR-T these agents did
not modify nitrites.
Figure 3 shows direct NOmeasurement in SR, NefR, and
NefR-T and the effect of in vitro administration of tempol.
Figure 3(a) shows recorders from typical experiments of
the effect of tempol on NO release in SR (upper panel),
NefR (middle panel), andNefR-T (bottom panel). Figure 3(b)
shows the average of these responses. First group of bars
shows the NO levels in basal conditions. NO release was
higher in SR than NefR. NefR-T improves the NO release.
Tempol had no effect in SR and NefR-T; however it was able
to increase NO in NefR (Figure 3(b), second group of bars).
In vitro administration of L-NAME was able to decrease
NO release in SR (−87 ± 1% from baseline; 𝑛 = 6; 𝑃 < 0.001;
paired Student’s 𝑡-test) and NefR (−64 ± 1% from baseline;
𝑛 = 8; 𝑃 < 0.01; paired Student’s 𝑡-test). Similar inhibition
was obtained in NefR-T (data not shown).
3.4. Membrane Potential. Figure 4 shows the MP in basal
conditions and after administration of L-NAME in unrubbed
aortic rings from SR, NefR, and NefR-T. Basal MP was higher
in NefR than SR. NefR-T partially recovered MP values
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Figure 3: Effect of tempol 10−5M on NO levels (a) Typical experiment of direct measurement of NO in unrubbed aortic rings from SR
(upper), NefR (middle), and NefR-T (lower) and the effect of tempol (arrows). (b) Average of effect of tempol on direct measurement of NO
in unrubbed aortic rings of SR (white bars), NefR (black bars), and NefR-T (gray bars). ∗∗𝑃 < 0.01 NefR-T versus SR; ∗∗∗𝑃 < 0.001 NefR
versus SR; +++𝑃 < 0.001 tempol versus basal. Two way ANOVA. Data are expressed as mean ± standard error. The number of rings is given
in parentheses.
(Figure 4, first group of bars). In vitro treatment with L-
NAME produced a partial depolarization in SR and NefR-T
but not in NefR (Figure 4, second group of bars).
In vitro administration of tempol induced a hyperpolar-
izing effect only in NefR (MP: −30 ± 1mV; 124 ± 5% from
baseline; 𝑛 = 6; 𝑃 < 0.01 paired Student’s 𝑡-test).
3.5. Oxidative Stress. In aortic rings, GSH levels were higher
in SR (33.9± 7.2 𝜇mol/mg protein; 𝑛 = 6) thanNefR (3.8± 1.4;
𝑛 = 6; 𝑃 < 0.001). However, similar GSSG levels were found
in SR (5.6 ± 0.6 𝜇mol/mg protein; 𝑛 = 6) and NefR (5.2 ± 0.3;
𝑛 = 6; 𝑃: NS). In agreement, the GSH/GSSG ratio was higher
in SR (6.3 ± 1.0; 𝑛 = 6) than NefR (0.7 ± 0.2; 𝑛 = 6; 𝑃 < 0.001;
One way ANOVA). NefR-T improves GSH/GSSG (data not
shown).
In aortic rings, TBARS levels were higher in NefR (5.2 ±
0.7 nmol/mg protein; 𝑛 = 6) than SR rings (1.5 ± 0.3; 𝑛 = 6;
𝑃 < 0.001; One way ANOVA). NefR-T decreased the TBARS
levels (1.2 ± 0.6 nmol/mg protein; 𝑛 = 6; 𝑃 < 0.001 versus
NefR; One way ANOVA). No significant differences were
found between SR and NefR-T in TBARS levels (𝑃: NS; One
way ANOVA).
4. Discussion
The novel finding of this study is that (1) subtotal nephrec-
tomy induces an associated hypertension with an increased
basal tone, an endothelial dysfunction, and an oxidative state
and that (2) in vivo treatment with tempol improves arterial
basal tone, NO levels, and oxidative stress without revers-
ing hypertension, indicating that oxidative stress could be
implicated in the vascular alterations, and that these disorders
would occur early and independently to hypertension.
It has been demonstrated that several models of renal
mass reduction induce CKD and alter the renal function
[6, 21, 22]. On the other hand, CKD is frequently associated
with hypertension [23, 24]. A lot of evidence has reported
that the decreased renal mass is a cardiovascular risk factor
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Figure 4: Membrane potential (MP) in unrubbed aortic rings from
SR (white bars), NefR (black bars), and NefR-T (gray bars) in basal
conditions (Krebs) and the effect of administration of L-NAME
10−4M. ∗∗∗𝑃 < 0.001 NefR basal versus SR basal; ∗𝑃 < 0.05 NefR-
T basal versus SR basal; ++SR L-NAME 𝑃 < 0.01 versus SR basal;
+
𝑃 < 0.05 NefR-T L-NAME versus NefR-T basal; †𝑃 < 0.05 NefR-
T basal versus NefR basal. Two way ANOVA. Data are expressed as
mean ± standard error.The number of rings is given in parentheses.
[2]. In experimental models, some authors have reported
that the loss of renal mass induces hemodynamic alterations
that lead to hypertension [4]; however the physiopathological
mechanisms involved remain unclear. It is known that an
endothelial function and an NO bioavailability play a pivotal
role in the balance of vascular tone. Likewise, an increase in
basal tone may be associated with the presence of oxidative
stress. In a model of CKD with loss of renal mass associated
with renal ischemia, it has been shown that oxidative stress is
implicated in the hypertension developed [25]. In our work,
nonischemic 5/6 nephrectomized rats showed hypertension
associated with an impaired endothelial function and a
decreased NO levels. In agreement with this, other authors
found that the vessels from nonischemic 5/6 nephrectomized
rats have a decreased Ach-response indicating an endothelial
dysfunction [26]; however, these alterations were developed
in the absence of hypertension.
In relation to the increased basal tone in NefR, previous
reports from our laboratory have shown an increased basal
tone in coarctation-hypertensive rats [12] and SHR [11]. Also,
we were able to increase the basal tone by an “in vitro” sensi-
tizing manoeuvre in vessels from rabbits [27] and toads [28].
For this purpose, normotensive aortic rings were previously
sensitizedwith a vasoconstrictor agent, washedwith Krebs by
120min, and then stimulated with a vasorelaxant agent. On
the other hand, it is known that oxidative stress could alter
the basal tone. In this sense, in our laboratory, we found that
the basal tone of SHR was increased by oxidative stress [11].
Also, it was reported that the oxidant agent H
2
O
2
could alter
vascular contractility in normotensive and hypertensive rats
[29]. This is in agreement with the finding from a present
report, in which antioxidant treatment decreased the basal
tone in aortic rings from NefR. An other result from present
work that supports the fact that vessels of NefR presented an
increased oxidative stress is the altered GSH/GSSG ratio and
increased TBARS levels.
Despite that NefR and NefR-T showed similar values of
MAP, the aortic rings from NefR-T decreased basal tone,
evidenced by a lower SNP response. This fact could indicate
that in vivo treatment with antioxidant agents may decrease
basal tone independently of the blood pressure values. At
variance with our findings, in othermodel of CKD associated
with renal ischemia [25], tempol decreased MAP values.
This difference may be explained since renal ischemia is not
present in our model of CKD and, it is known that renal
ischemia is strongly associated with great activation of renin-
angiotensin system in which angiotensin II (Ang II) not only
has hemodynamic effects but also has tissue actions, which
results in an increase of oxidative stress. Accordingly, some
works have demonstrated that Ang II activation of NADPH
increases reactive oxygen species [30].However, in ourmodel
these additional effects of Ang II on oxidative stress are not
present.
The role of endothelium in the vascular function and
its association with CKD are well known. In present work
we found that NefR showed an endothelial dysfunction with
decreased NO levels. The fact that in vivo treatment with
tempol improves endothelial function andNO bioavailability
indicates that the endotheliumdamage is produced, at least in
part, by oxidative stress.
In our work we found that NefR decreased urinary
nitrites. Similar findings have been reported by other authors,
who also found reduced renal NO-synthases in a similar
model of subtotal nephrectomy [7]. Unlike other works
performed in models of subtotal nephrectomy, in our study
we measured nitrite and NO in vessels. We observed that
the decreased vascular NO levels were increased by tempol
(in vivo and in vitro), indicating a role of oxidative stress in
the vascular NO bioavailability. In accordance, it has been
reported that superoxide dismutase improves NO-dependent
vasorelaxation in other models of CKD [25].
Assuming that the oxidative stress decreases NO levels
and increases the basal tone [11], we could hypothesize that
antioxidant treatment improves NO bioavailability and also
decreases basal tone. In fact, in vitro administration of tempol
improves NO bioavailability and reduces the SNP response in
aortic rings.Moreover, the in vivo treatment with antioxidant
agents (NefR-T) showed similar results.
In conclusion, in the present work we described, for the
first time, that aortic rings from nonischemic 5/6 nephrec-
tomized rats presented an increased basal tone related to
endothelial dysfunction and decreased NO levels. The fact
that in vitro and in vivo treatments with tempol improve
the NO bioavailability and the basal tone, without decreasing
the values of blood pressure, indicates that oxidative stress
could be implicated in the vascular alterations and that
these disorders would occur early and independently to
hypertension.
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